Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Apr-24 5:20 PM View:  | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 19-Apr-24 | Sale | 3,361 | $24.89 | $83,668.70 | (1%) 229.17K to 225.81K | |
| 19-Apr-24 5:20 PM View: | Pauwels Eric CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 17-Apr-24 | Sale | 787 | $25.14 | $19,781.20 | (1%) 68.48K to 67.69K | |
| 19-Apr-24 5:20 PM View: | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 17-Apr-24 | Sale | 1,307 | $25.14 | $32,851.40 | (< 1%) 230.47K to 229.17K | |
| 04-Apr-24 5:16 PM View: | Golden Lee Scott EVP & CHIEF MEDICAL OFFICER | Ptc Therapeutics, Inc. (PTCT) | 02-Apr-24 | Sale | 526 | $28.37 | $14,922.60 | (< 1%) 60.51K to 59.99K | |
| 16-Feb-24 4:10 PM View: | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 70,000 | -- | -- | 44% 160.47K to 230.47K | |
| 16-Feb-24 5:00 PM View: | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 16,900 | -- | -- | 48% 35.53K to 52.43K | |
| 16-Feb-24 4:10 PM View: | Zeldis Jerome B Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 38% 10.5K to 14.5K | |
| 16-Feb-24 4:20 PM View: | Bell William F. Jr. Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 63% 6.33K to 10.33K | |
| 16-Feb-24 4:10 PM View: | Golden Lee Scott Chief Medical Officer | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 22,600 | -- | -- | 60% 37.91K to 60.51K | |
| 16-Feb-24 4:11 PM View: | Gravier Pierre CHIEF FINANCIAL OFFICER | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 22,100 | -- | -- | 66% 33.7K to 55.8K | |
| 16-Feb-24 4:10 PM View: | Jacobson Allan Steven Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 32% 12.35K to 16.35K | |
| 16-Feb-24 5:00 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 25,000 | -- | -- | 39% 64.91K to 89.91K | |
| 16-Feb-24 4:10 PM View: | Reeve Emma Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 56% 7.2K to 11.2K | |
| 16-Feb-24 5:00 PM View: | Pauwels Eric Chief Business Officer | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 24,300 | -- | -- | 55% 44.18K to 68.48K | |
| 16-Feb-24 4:20 PM View: | Southwell David P Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 38% 10.5K to 14.5K | |
| 16-Feb-24 4:10 PM View: | Smith Mary L. Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 41% 9.81K to 13.81K | |
| 16-Feb-24 5:00 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 870 | -- | -- | < 1% 89.91K to 90.78K | |
| 16-Feb-24 4:10 PM View: | Steele Glenn Jr Md Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 38% 10.5K to 14.5K | |
| 16-Feb-24 4:10 PM View: | Young Alethia Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 44% 9.07K to 13.07K | |
| 16-Feb-24 4:25 PM View: | Schmertzler Michael Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 8,000 | -- | -- | 7% 115.27K to 123.27K | |
| 16-Feb-24 4:16 PM View: | Okey Stephanie Director | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 68% 5.87K to 9.87K | |
| 16-Feb-24 4:10 PM View: | Boulding Mark Elliott Exec. VP and CLO | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 21,200 | -- | -- | 30% 71.19K to 92.39K | |
| 01-Feb-24 4:18 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 30-Jan-24 | Sale | 618 | $27.25 | $16,841.00 | (< 1%) 65.55K to 64.94K | |
| 01-Feb-24 4:17 PM View: | Boulding Mark Elliott Exec. VP and CLO | Ptc Therapeutics, Inc. (PTCT) | 30-Jan-24 | Sale | 794 | $27.25 | $21,637.10 | (1%) 71.98K to 71.19K | |
| 01-Feb-24 4:15 PM View: | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Ptc Therapeutics, Inc. (PTCT) | 30-Jan-24 | Sale | 318 | $27.25 | $8,665.75 | (< 1%) 35.85K to 35.53K | |
| 01-Feb-24 4:18 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 30-Jan-24 | Sale | 28 | $27.25 | $763.02 | (< 1%) 64.94K to 64.91K | |
| 01-Feb-24 4:16 PM View: | Pauwels Eric Chief Business Officer | Ptc Therapeutics, Inc. (PTCT) | 30-Jan-24 | Sale | 366 | $27.25 | $9,973.79 | (< 1%) 44.55K to 44.18K | |
| 24-Jan-24 4:30 PM View: | Jacobson Allan Steven Director | Ptc Therapeutics, Inc. (PTCT) | 22-Jan-24 | Planned Option Sale | 10,000 | $27.38 | $273,804.00 | (45%) 22.35K to 12.35K | |
| 24-Jan-24 4:30 PM View: | Jacobson Allan Steven Director | Ptc Therapeutics, Inc. (PTCT) | 22-Jan-24 | Option Exercise | 10,000 | $27.05 | $270,500.00 | 81% 12.35K to 22.35K | |
| 10-Jan-24 4:03 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 100 | $29.01 | $2,901.48 | (< 1%) 65.65K to 65.55K | |
| 10-Jan-24 4:09 PM View: | Pauwels Eric Chief Business Officer | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 2,065 | $29.01 | $59,915.60 | (4%) 46.61K to 44.55K | |
| 10-Jan-24 4:11 PM View: | Utter Christine Marie SVP, Finance & CAO | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 1,653 | $29.01 | $47,961.50 | (4%) 37.5K to 35.85K | |
| 10-Jan-24 4:04 PM View: | Boulding Mark Elliott Exec. VP and CLO | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 1,938 | $29.01 | $56,230.70 | (3%) 73.92K to 71.98K | |
| 10-Jan-24 4:08 PM View: | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 5,443 | $29.01 | $157,928.00 | (3%) 165.92K to 160.47K | |
| 10-Jan-24 4:03 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 1,521 | $29.01 | $44,131.50 | (2%) 67.17K to 65.65K | |
| 10-Jan-24 4:06 PM View: | Golden Lee Scott Chief Medical Officer | Ptc Therapeutics, Inc. (PTCT) | 09-Jan-24 | Sale | 1,225 | $29.01 | $35,543.10 | (3%) 39.14K to 37.91K | |
| 10-Jan-24 4:03 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 1,236 | $28.64 | $35,399.40 | (2%) 68.46K to 67.23K | |
| 10-Jan-24 4:04 PM View: | Boulding Mark Elliott Exec. VP and CLO | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 1,457 | $28.64 | $41,728.90 | (2%) 75.38K to 73.92K | |
| 10-Jan-24 4:08 PM View: | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 2,237 | $28.64 | $64,068.40 | (1%) 168.16K to 165.92K | |
| 10-Jan-24 4:03 PM View: | Almstead Neil Gregory Chief Technical Ops Officer | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 53 | $28.64 | $1,517.94 | (< 1%) 67.23K to 67.17K | |
| 10-Jan-24 4:10 PM View: | Schmertzler Michael Director | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale (Planned) | 1,500 | $27.81 | $41,715.00 | (1%) 116.77K to 115.27K | |
| 10-Jan-24 4:06 PM View: | Golden Lee Scott Chief Medical Officer | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 775 | $28.64 | $22,196.20 | (2%) 39.91K to 39.14K | |
| 10-Jan-24 4:09 PM View: | Pauwels Eric Chief Business Officer | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 1,569 | $28.64 | $44,936.60 | (3%) 48.18K to 46.61K | |
| 10-Jan-24 4:11 PM View: | Utter Christine Marie SVP, Finance & CAO | Ptc Therapeutics, Inc. (PTCT) | 08-Jan-24 | Sale | 1,188 | $28.64 | $34,024.70 | (3%) 38.69K to 37.5K | |
| 09-Jan-24 4:29 PM View: | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 05-Jan-24 | Sale | 10,107 | $27.15 | $274,393.00 | (6%) 178.26K to 168.16K | |
| 28-Dec-23 5:12 PM View: | Klein Matthew B. CHIEF EXECUTIVE OFFICER Director | Ptc Therapeutics, Inc. (PTCT) | 28-Dec-23 | Grant | 75,000 | -- | -- | 73% 102.96K to 177.96K | |
| 14-Dec-23 4:38 PM View: | Gravier Pierre CHIEF FINANCIAL OFFICER | Ptc Therapeutics, Inc. (PTCT) | 12-Dec-23 | Private Purchase | 7,700 | $25.81 | $198,736.00 | 30% 26.0K to 33.7K | |
| 08-Sep-23 4:02 PM View: | Young Alethia Director | Ptc Therapeutics, Inc. (PTCT) | 06-Sep-23 | Option Exercise | 11,666 | $27.85 | $324,898.00 | 129% 9.07K to 20.73K | |
| 08-Sep-23 4:02 PM View: | Young Alethia Director | Ptc Therapeutics, Inc. (PTCT) | 06-Sep-23 | Option Sale | 11,666 | $39.86 | $464,972.00 | (56%) 20.73K to 9.07K | |
| 17-Jul-23 4:51 PM View: | Gravier Pierre CHIEF FINANCIAL OFFICER | Ptc Therapeutics, Inc. (PTCT) | 13-Jul-23 | Grant | 26,000 | -- | -- | 100% 0 to 26.0K |
